in3

in3

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Edelweiss Connect (6 days ago)
Edelweiss Connect at front of the move to non-animal testing with SaferSkin™ https://t.co/CLqvbKP6Xj #AnimalTesting… https://t.co/K2uQcj6qw7
Edelweiss Connect (2 weeks ago)
@UniLeiden Bob van de Water leads EU-ToxRisk. Aiming for paradigm shift in toxicological testing: reliable, animal-… https://t.co/DNekLz31pX
Edelweiss Connect (2 weeks ago)
#eutoxrisk Bob van de Water: "10 case studies, different partners in different disciplines, all generating data! Ed… https://t.co/FxP9IQwWSQ
Edelweiss Connect (2 weeks ago)
Prof Bob van de Water, coordinator of EU-ToxRisk, largest EU programme in toxicology. 39 partner organisations acro… https://t.co/3obHsS2mCv
Edelweiss Connect (2 weeks ago)
@UniLeiden spin-off develops 50+ cell lines “reporting” stress response signaling toxicity. Genetically-engineered… https://t.co/xSa4JZsGOA

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@edelweissconnect.com